CURE Pharmaceutical Issues Letter to Shareholders

OXNARD, Calif. – CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today that it has issued a letter to its shareholders providing commentary on the Company’s recent announcements and upcoming plans. Highlights of the letter include: The Company’s efforts to…